Maya C Thaman

Title: Maya C. Thaman: Innovator in Therapeutic Compounds

Introduction

Maya C. Thaman is a prominent inventor based in Ventura, California. She has made significant contributions to the field of therapeutic compounds, particularly in the treatment of various inflammatory and autoimmune diseases. With a total of 2 patents, her work is paving the way for innovative medical solutions.

Latest Patents

Maya's latest patents include groundbreaking inventions such as "Phthalazine compounds and methods of use." This invention introduces a new class of compounds that are useful for the prophylaxis and treatment of protein kinase-mediated diseases, including inflammation and related conditions. The compounds are characterized by a general Formula I, which is detailed in her patent documentation. Additionally, she has developed "Substituted heterocyclic compounds and methods of use," which relates to therapeutic diazobicyclo pyridines. These compounds are aimed at treating a wide range of conditions, including various forms of arthritis, autoimmune diseases, and cancers where specific kinases are activated.

Career Highlights

Maya C. Thaman is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. Her work at Amgen has allowed her to focus on developing new therapeutic strategies that address complex health issues.

Collaborations

Throughout her career, Maya has collaborated with notable colleagues, including Anthony B. Reed and Kelvin K. C. Sham. These collaborations have enhanced her research and contributed to the advancement of her patented technologies.

Conclusion

Maya C. Thaman is a trailblazer in the field of therapeutic innovations, with her patents reflecting her commitment to improving healthcare outcomes. Her contributions are vital in the ongoing fight against various diseases, showcasing the importance of innovation in medicine.